Clinical Study of IBI362 in Healthy Chinese Male Subjects
Condition: Overweight/Obesity Interventions: Drug: IBI362 liquid formulation; Drug: IBI362 lyophilized powder Sponsor: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials